LIPOCINE INC. Gain (Loss) Related to Litigation Settlement
LIPOCINE INC. (LPCN) reported Gain (Loss) Related to Litigation Settlement of $250.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-03-07
- LIPOCINE INC. gain (loss) related to litigation settlement for the quarter ending 2022-12-31 was $0.00.
- LIPOCINE INC. gain (loss) related to litigation settlement for the quarter ending 2022-09-30 was $0.00.
- LIPOCINE INC. gain (loss) related to litigation settlement for the quarter ending 2022-06-30 was $250.00K.
- LIPOCINE INC. gain (loss) related to litigation settlement for the quarter ending 2021-12-31 was $0.00.
- LIPOCINE INC. gain (loss) related to litigation settlement for fiscal 2022 was $250.00K.
- LIPOCINE INC. gain (loss) related to litigation settlement for fiscal 2021 was -$4.00M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $250.00K derived: sum of 3 quarters · filed 2024-03-07 | $250.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $250.00K derived: sum of 2 quarters · filed 2023-11-08 | $250.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $250.00K 10-Q · filed 2023-08-10 | $250.00K 10-Q · filed 2023-08-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | -$4.00M derived: sum of 3 quarters · filed 2023-03-10 | -$4.00M 10-K · filed 2023-03-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$4.00M derived: sum of 2 quarters · filed 2022-11-09 | -$4.00M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$4.00M 10-Q · filed 2022-08-08 | -$4.00M 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |